0001104659-24-027571.txt : 20240226 0001104659-24-027571.hdr.sgml : 20240226 20240226170055 ACCESSION NUMBER: 0001104659-24-027571 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240222 FILED AS OF DATE: 20240226 DATE AS OF CHANGE: 20240226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mottola Frank CENTRAL INDEX KEY: 0001804567 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 24679952 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 4 1 tm247055-4_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-22 0 0001356576 SUPERNUS PHARMACEUTICALS, INC. SUPN 0001804567 Mottola Frank C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850 0 1 0 0 SVP, Quality, GMP, Ops, IT 0 Common Stock 2024-02-22 4 A 0 750 0 A 6646 D Common Stock 2024-02-22 4 F 0 335 27.94 D 6311 D Restricted Stock Unit 2024-02-22 4 D 0 750 0 D Common Stock 750 1500 D Restricted Stock Unit 2024-02-22 4 A 0 5000 0 A Common Stock 5000 5000 D Employee Stock Option (Right to Buy) 27.94 2024-02-22 4 A 0 25000 0 A 2034-02-22 Common Stock 25000 25000 D Performance Share Unit 0 2024-02-22 4 A 0 990 0 A Common Stock 990 990 D Includes an aggregate of 215 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. The option vests in four equal annual installments beginning on February 22, 2025. On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022. /s/ Timothy C. Dec, as attorney-in-fact 2024-02-26